Clinical Trials and Research Studies
Phase 3
MK-3475 (SCH 9000475) as neoadjuvant and adjuvant therapy in Stage III-IVA resectable
Learn MorePhase 1
A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors
Learn MorePhase 1
A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad
Learn MorePhase N/A
A prospective multi-site trial of a point of care saliva based detection test based on soluble CD44 (OncAlert) for presence of disease in previously untreated oral cavity and oropharynx squamous cell carcinoma.
Learn More